Development of a new generation of immune response modifier|Simon Wilkinson,CEO,Innate Immunotherapeutics Ltd 00:10:00
Mr Carter has more than 30 years of expertise in professional accounting, investment banking, corporate finance and commercial / strategic planning roles. He has served as a member of the board of directors of NASDAQ listed Unilife Corporation since April 2006. He has also served as chief financial officer and company secretary of UnilifeMedical Solutions Limited. Jeff has been a chief financial officer of various other publicly listed healthcare companies and has also held senior positions with Coca Cola, Santos, Canadian Imperial Bank of Commerce and Touche Ross.
